Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_assertion type Assertion NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_head.
- NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_assertion description "[In this study, we show that the adenoma prevention activity of the COX-2 inhibitor celecoxib requires the concomitant presence of the 15-hydroxyprostaglandin dehydrogenase (15-PGDH) tumor suppressor gene, and that loss of 15-PGDH expression imparts resistance to celecoxib's anti-tumor effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_provenance.
- NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_assertion evidence source_evidence_literature NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_provenance.
- NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_assertion SIO_000772 19470469 NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_provenance.
- NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_assertion wasDerivedFrom befree-20140225 NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_provenance.
- NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_assertion wasGeneratedBy ECO_0000203 NP287883.RAokSn4m2SX_XBKQqQvwMR0xlWZXE7t10_2km30FA3yXM130_provenance.